Study Questions Benefit Of ICDs In Dialysis Patients, Cites Need For Research
This article was originally published in The Gray Sheet
Executive Summary
The benefit of implanting end-stage renal disease (ESRD) patients with defibrillators needs further evaluation, according to a study in the October issue of Heart Rhythm.
You may also be interested in...
Guidelines For Preventing Sudden Cardiac Death Could Impact ICD Sales
For the first time, physicians have access to comprehensive, widely endorsed guidelines for the prevention of sudden cardiac death - including clearer recommendations than ever before about when to treat various types of patients with implantable cardioverter defibrillators
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.